国际肿瘤学杂志
國際腫瘤學雜誌
국제종류학잡지
JOURNAL OF INTERNATIONAL ONCOLOGY
2011年
7期
537-540
,共4页
曾银朵%丁林潇潇%陈丽昆
曾銀朵%丁林瀟瀟%陳麗昆
증은타%정림소소%진려곤
脑肿瘤%癌,非小细胞肺%放射疗法%抗肿瘤药%外科手术
腦腫瘤%癌,非小細胞肺%放射療法%抗腫瘤藥%外科手術
뇌종류%암,비소세포폐%방사요법%항종류약%외과수술
Brain neoplasms%Carcinoma,non-small-cell lung%Radiotherapy%Antineoplastic agents%Surgical procedures
非小细胞肺癌(NSCLC)脑转移的治疗方法包括激素、抗惊厥药物治疗、手术、放疗、化疗.近年来分子靶向治疗如表皮生长因子(EGFR)酪氨酸激酶抑制剂(TKI)成为NSCLC脑转移的新的治疗选择.
非小細胞肺癌(NSCLC)腦轉移的治療方法包括激素、抗驚厥藥物治療、手術、放療、化療.近年來分子靶嚮治療如錶皮生長因子(EGFR)酪氨痠激酶抑製劑(TKI)成為NSCLC腦轉移的新的治療選擇.
비소세포폐암(NSCLC)뇌전이적치료방법포괄격소、항량궐약물치료、수술、방료、화료.근년래분자파향치료여표피생장인자(EGFR)락안산격매억제제(TKI)성위NSCLC뇌전이적신적치료선택.
Therapeutic approaches to brain metastases from non-small cell lung cancer ( NSCLC ) include corticosteroids, anticonvulsants, surgery, radiotherapy and chemotherapy. In recent years, molecular targeted therapy such as the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) has become a new option. This article discussed the roles of surgery, brain radiation, chemotherapy, targeted therapy , and other new directions in the treatment of patients with brain metastases from NSCLC.